DE69523585T2 - Wundheilmittel - Google Patents

Wundheilmittel

Info

Publication number
DE69523585T2
DE69523585T2 DE69523585T DE69523585T DE69523585T2 DE 69523585 T2 DE69523585 T2 DE 69523585T2 DE 69523585 T DE69523585 T DE 69523585T DE 69523585 T DE69523585 T DE 69523585T DE 69523585 T2 DE69523585 T2 DE 69523585T2
Authority
DE
Germany
Prior art keywords
pct
chitosan
polysaccharide
composition
heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69523585T
Other languages
English (en)
Other versions
DE69523585D1 (de
Inventor
Ibrahim Gouda
Olle Larm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicarb AB
Original Assignee
Medicarb AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb AB filed Critical Medicarb AB
Application granted granted Critical
Publication of DE69523585D1 publication Critical patent/DE69523585D1/de
Publication of DE69523585T2 publication Critical patent/DE69523585T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69523585T 1994-07-19 1995-07-18 Wundheilmittel Expired - Lifetime DE69523585T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402531A SE9402531L (sv) 1994-07-19 1994-07-19 Sårläkningsmedel
PCT/SE1995/000875 WO1996002260A1 (en) 1994-07-19 1995-07-18 Wound healing agent

Publications (2)

Publication Number Publication Date
DE69523585D1 DE69523585D1 (de) 2001-12-06
DE69523585T2 true DE69523585T2 (de) 2002-04-11

Family

ID=20394771

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69523585T Expired - Lifetime DE69523585T2 (de) 1994-07-19 1995-07-18 Wundheilmittel

Country Status (11)

Country Link
US (1) US5902798A (de)
EP (1) EP0759760B1 (de)
JP (1) JP3337472B2 (de)
AT (1) ATE207753T1 (de)
AU (1) AU691322B2 (de)
CA (1) CA2194976C (de)
DE (1) DE69523585T2 (de)
DK (1) DK0759760T3 (de)
ES (1) ES2161903T3 (de)
SE (1) SE9402531L (de)
WO (1) WO1996002260A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576839A (en) * 1991-09-25 1996-11-19 Minolta Camera Kabushiki Kaisha Camera system including a separatable recorder
SE508760C2 (sv) 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
NL1011680C2 (nl) 1999-03-26 2000-09-27 Nutricia Nv Voedingssamenstellen die licht negatief geladen, niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
US6391334B1 (en) 1999-10-25 2002-05-21 Amway Corporation Barrier-forming composition
ES2491866T3 (es) * 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Disolución biopolimérica acuosa autogelificante controlada por la temperatura y dependiente del pH
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
DE60003459T2 (de) * 1999-12-09 2004-05-06 Biosyntech Canada Inc., Laval Mineral-polymer hybrid-zusammensetzung
GB9929472D0 (en) * 1999-12-13 2000-02-09 Btg Int Ltd Polymeric film
BR0112109A (pt) * 2000-06-29 2007-05-29 Biosyntech Canada Inc composição e método para a correção e regeneração de cartilagem e outros tecidos
CA2429168C (en) * 2000-11-15 2010-06-08 Bio Syntech Canada Inc. Method for restoring a damaged or degenerated intervertebral disc
US6623761B2 (en) 2000-12-22 2003-09-23 Hassan Emadeldin M. Method of making nanoparticles of substantially water insoluble materials
KR20020066024A (ko) * 2001-02-08 2002-08-14 굿젠 주식회사 수용성 키토산과 헤파린으로 이루어진 상처 치유 촉진연고 조성물과 필름 및 제품
SE522529C2 (sv) 2001-04-12 2004-02-17 Medicarb Ab Effervescent fastämneskomposition innefattande som aktiv komponent kitosan, dess derivat och salter därav, användning samt framställning därav
BR0208858A (pt) * 2001-04-12 2004-10-19 Medicarb Ab Composição de matéria sólida efervescente, uso da mesma, método para tratamento de um mamìfero que sofre de uma ferida dermal, para tratamento de cicatrização de feridas de um animal lactante que sofre de mastite e para tratamento profilático de um animal lactante propenso a desenvolver mastite
US7297343B2 (en) * 2001-07-31 2007-11-20 Biosurface Engineering Technologies, Inc. Bioactive medical films
KR20020060627A (ko) * 2002-01-16 2002-07-18 조석형 키토산/음이온성 다당류의 창상 치유제
US7371719B2 (en) 2002-02-15 2008-05-13 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
CA2493083C (en) * 2002-07-16 2012-11-06 Bio Syntech Canada Inc. Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
US7554021B2 (en) 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
US20070053848A1 (en) * 2003-08-26 2007-03-08 Stockel Richard F Antimicrobial materials for dental care applications
JP2006347883A (ja) * 2003-09-08 2006-12-28 Neetec:Kk 糖鎖含有キトサン誘導体及びグリコサミノグリカンを含有する医療用組成物
KR20070004560A (ko) 2003-12-05 2007-01-09 노오쓰웨스턴 유니버시티 성장 인자 전달을 위한 자가조립 펩티드 친양매성 화합물들및 관련 방법들
US20050136024A1 (en) * 2003-12-22 2005-06-23 Stockel Richard F. Dermatological compositions
US20070086977A1 (en) * 2003-12-22 2007-04-19 Stockel Richard F Method of treating dermatological conditions
US20050283004A1 (en) * 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
US7851445B2 (en) * 2005-03-04 2010-12-14 Northwestern University Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use
WO2007051311A1 (en) * 2005-11-04 2007-05-10 Bio Syntech Canada Inc. Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state
DE102006020035A1 (de) 2006-04-26 2007-10-31 B. Braun Melsungen Ag Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen
EP1958613A1 (de) * 2007-02-15 2008-08-20 Polichem S.A. Dermale filmbildende flüssige Formulierungen zur Wirkstofffreisetzung auf der Haut
US8076295B2 (en) 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
DK2195039T3 (en) 2007-08-28 2017-01-30 Otago Innovation Ltd SURGICAL HYDROGEL
SI2679278T1 (en) 2008-11-20 2018-02-28 Laboratori Derivati Organici S.P.A. Dermatological compositions comprising heparan sulphate
RU2519225C2 (ru) * 2008-12-06 2014-06-10 Б. Браун Мельзунген Аг Опосредующие транспорт коллоидные лекарственные соединения
BRPI1013656B1 (pt) 2009-03-31 2019-04-30 B. Braun Melsungen Ag Produto de ligação e seu uso, formulação farmacêutica e processo para preparar um produto de ligação
WO2010120830A1 (en) 2009-04-13 2010-10-21 Northwestern University Novel peptide-based scaffolds for cartilage regeneration and methods for their use
CN102458419A (zh) * 2009-06-10 2012-05-16 埃克塞拉医学有限责任公司 组合物用于治疗粘膜炎的用途
JP5752123B2 (ja) 2009-09-01 2015-07-22 メドヴェント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング キトサン組織被覆材
JP2013521300A (ja) * 2010-03-03 2013-06-10 ネオキュティス エスアー 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法
JP6437916B2 (ja) 2013-08-13 2018-12-12 生化学工業株式会社 カチオン化キトサンを含有する医薬
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
FR3016882A1 (fr) 2014-01-30 2015-07-31 Sofradim Production Procede de preparation de chitosane a haut degre d’acetylation
US10126298B2 (en) 2015-05-04 2018-11-13 Arman Nabatian Hydrogels containing embedded substrates for targeted binding of molecules
US9248160B1 (en) * 2015-07-28 2016-02-02 Zo Skin Health, Inc. Post-procedure skin care systems, compositions, and methods of use thereof
CN111587129A (zh) 2018-01-12 2020-08-25 波士顿科学国际有限公司 实现止血的粉末
EP3787593A1 (de) 2018-05-04 2021-03-10 Bonoss Medical Aktiebolag Zusammensetzung zur verminderung der narbenbildung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378017A (en) * 1980-03-21 1983-03-29 Kureha Kagaku Kogyo Kabushiki Kaisha Composite material of de-N-acetylated chitin and fibrous collagen
US4326532A (en) * 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US5002582A (en) * 1982-09-29 1991-03-26 Bio-Metric Systems, Inc. Preparation of polymeric surfaces via covalently attaching polymers
CA1202904A (en) * 1983-11-21 1986-04-08 Brian G. Sparkes Chitosan based wound dressing materials
JPS61253065A (ja) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
JP3205104B2 (ja) * 1992-01-20 2001-09-04 川研ファインケミカル株式会社 化粧料
SE9402529D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Anti-adherensmedel

Also Published As

Publication number Publication date
AU3090295A (en) 1996-02-16
ATE207753T1 (de) 2001-11-15
JPH10502665A (ja) 1998-03-10
SE9402531L (sv) 1996-01-20
AU691322B2 (en) 1998-05-14
US5902798A (en) 1999-05-11
CA2194976C (en) 2002-04-30
SE9402531D0 (sv) 1994-07-19
EP0759760A1 (de) 1997-03-05
WO1996002260A1 (en) 1996-02-01
DK0759760T3 (da) 2001-11-26
JP3337472B2 (ja) 2002-10-21
CA2194976A1 (en) 1996-02-01
EP0759760B1 (de) 2001-10-31
DE69523585D1 (de) 2001-12-06
ES2161903T3 (es) 2001-12-16

Similar Documents

Publication Publication Date Title
DE69523585T2 (de) Wundheilmittel
US5929050A (en) Chondroitin sulfate composition and method for wound treatment
KR970704459A (ko) 경조직 자극제(Hard Tissue Stimulating Agent)
NO20035569D0 (no) Sårbandasje og metode for kontroll av livstruende bl degree dning
AR003439A1 (es) Composicion de polisacaridos injertados con antioxidante y metodo para su preparacion.
BR0304601A (pt) Curativo de ferimento hemostático contendo polissacarìdeos modificados por aldeìdo
BR9906477A (pt) Cicatrizante de feridas enriquecido com plaquetas aperfeiçoado
NZ290218A (en) Composition to reduce adhesion in wound healing
RU97102350A (ru) Анти-адгезионный агент
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
EE9900470A (et) Tsinkhüaluronaadi kasutamine peptilise haavandi vastu
PT855916E (pt) Composicao farmaceutica contendo um estimulador de activina ou inibina
DK0921806T3 (da) Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser
BR9407669A (pt) Bandagem de ferida que compreende alginato
SE9303612D0 (sv) New use
FI963785A (fi) Hypokolesteroleemisia, antiateroskleroottisia ja hypotriglyserideemisiä merkaptoasetyyliamidijohdannaisia
DE69514912D1 (de) Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition